-
2019.05
The molecular and immune characteristics, antitumor activity...
ASCO 2019
Background: MET exon 14 (METex14) skipping caused by certain mutations in splice sites of METex14 ...
了 解 详 情
-
2019.05
The cross talk between the molecular alterations and tumor i...
ASCO 2019
Background: The previous study indicated that the biomarkers of molecular alterations and tumor im...
了 解 详 情
-
2019.05
The mutational landscape of MSI-H and MSS colorectal cancer
ASCO 2019
Background: The microsatellite instability-high (MSI-H) phenotype confers good prognosis and great...
了 解 详 情
-
2019.05
The mutational profile analysis of extramural vascular invas...
ASCO 2019
Background: Extramural vascular invasion(EMVI) is a known independent predictor of poor prognosis ...
了 解 详 情
-
2019.05
Tracking the tumor evolution of patients with recurrence of ...
ASCO 2019
Background: After primary surgical resection, quite a proportion of breast cancer survivors would ...
了 解 详 情
-
2019.05
Transcriptional characterization of immune microenvironment ...
ASCO 2019
Background: The resection of early stage NSCLC offers patients the best hope of a cure. However, t...
了 解 详 情
-
2019.05
The mutational profile analysis of different response to neo...
ASCO 2019
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant diseases...
了 解 详 情
-
2019.05
The mutational landscape of circulating cell-free DNA to ide...
ASCO 2019
Background: The neoadjuvant chemotherapy plays an important role in the current treatment of color...
了 解 详 情
-
2019.05
Association of high copy number instability (CNI) score with...
ASCO 2019
Background: As the fifth most common malignancies and the third leading cause of cancer death in t...
了 解 详 情
-
2019.05
Tumor copy number alteration (CNA) burden as a prognostic fa...
ASCO 2019
Background: Gastric cancer (GC) is associated with high morbidity and mortality rates in the world...
了 解 详 情
